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Abstract: Ipomoea pes-caprae (L.) R. Br., Convolvulaceae, is a medicinal plant that 
grows abundantly as a pan-tropical stand plant. The 32 (two factors and three levels) 
factorial design, was applied to determine the best time and drug/solvent proportion 
to maximize the fl avonoid content in the hydroethanolic extract by maceration 
process. The antinociceptive and anti-infl ammatory effects were studied at 5-20 mg/
kg, i.p., using the writhing test and carrageenan-induced pleurisy models in mice. 
The optimized extract was able to inhibit more than 50% of abdominal writhing at 
20 mg/kg, with 55.88%±2.4 of maximum inhibition. Indomethacin, used as positive 
control, inhibited 64.86% at 10 mg/kg. In the pleurisy model, the extract produced 
dose-dependent inhibition of the fi rst phase of infl ammation (4 h) in the pleural cavity 
induced by injection of carrageenan (1%) in mice. It inhibited 50%±0.82 (p<0.01) of 
exudation induced by carrageenan, and 60.88%±0.14 (p<0.01) of leukocyte migration 
to the pleural cavity. In conclusion, the results validate the technological conditions 
of the maceration process to produce an optimized bioactive herb extract for the 
development of analgesic and anti-infl ammatory phytopharmaceuticals using 70 °GL 
ethanol, a plant to solvent ratio of 12.5% (w/v), and ten days of maceration. 
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Introduction
 Ipomoea pes-caprae (L.) R. Br., Convolvulaceae, 
known in English as bayhops, beach morning glory, and 
goat's-foot-convolvulus, and in Brazil as “salsa-da-praia”, 
“batateira-da-praia” or “pé-de-cabra”, has been used as a 
herb remedy in many countries to treat infl ammation, colic, 
diuretic disorders, gonorrhea, pain etc. (Pongprayoon et 
al., 1989; Assis et al., 1994; Khan et al., 1994).
 Previous studies have confi rmed some 
pharmacological properties of this plant. Extract of 
petroleum ether caused concentration-dependant inhibition 
of the contraction of guinea-pig ileum contractions 
stimulated by different neurotransmitters (Pongprayoon 
et al., 1989). Bioassay-guided fractionation of this extract 
resulted in the isolation of β-damascenone and E-phytol, 
which were equipotent to papaverine (Pongprayoon et al., 
1992). Another interesting action demonstrated by this 
plant was its ability to neutralize or inactivate jellyfi sh 
venoms (Pongprayoon et al., 1991a). Khan et al. (1994) 
reported the insulinogenic and hypoglycemic activities of 
the alcohol extract of the leaves. Previous studies carried 
out by our research group have revealed that the methanol 
extract from the whole plant exhibits potent and signifi cant 
antinociceptive properties against acetic acid-induced 
abdominal constrictions and neurogenic and infl ammatory 
phases of formalin-induced pain, probably associated 
to ethyl acetate fraction, as well as to glochidona, α and 
β-amyrin acetate, betulinic acid and isoquercitrin, being 
equipotent to some analgesic drugs (Krogh et al., 1999; 
Souza et al., 2000). 
 Considering the popular use of this plant to 
treat pain and inflammation, as well as the promising 
previous experimental data and its abundance in 
Brazil, the first end point of the study was to develop 
an herb extract using an adequate solvent for industrial 
scaling up, with lower toxicity, less environmentally 
hazardous, associated with a simple extraction method. 
Then, we attempted to develop hydroethanolic extracts 
by maceration process, using factorial design to find 
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out the extraction conditions for the highest flavonoid 
content, and antinociceptive and anti-inflammatory 
effects analysis of the selected extract. 
Material and Methods
Plant material
 The botanical material was collected from 
Esplanada Beach (Jaguaruna-SC, Brazil) in February 
2006. A voucher was deposited at the Barbosa Rodrigues 
Herbarium (Itajaí-SC, Brazil) under number V.C. Filho 
009. The leaves, stems and other aerial parts (flower buds, 
seeds and flowers) were manually separated, cleaned and 
dried in an air oven at 35 ºC for eleven days. After drying, 
each set of each plant material was ground in a hammer 
mill (outlet sieve =3 mm) and the average size of the 
particles was determined by sieving. 
Previous studies for extraction
 The ethanol graduation was first investigated 
by ethanol extractable matter (EM) from 1.0 g of aerial 
parts decocted with 100 g of 40, 50, 60, 70 or 80 °GL 
ethanol, under reflux for 10 min. In another set of 
experiments, an extract (5%, w/w) of each solvent was 
prepared by maceration for seven days, in a hermetically 
sealed amber glass bottle, stirred twice a day. 
 The total flavonoid content (TFC), 
expressed as quercetin (g%, w/w), was determined 
spectrophotometrically (420 nm) for 15.0 g of each 
sample solution, after selective extraction, acid 
hydrolysis and complexation with AlCl3, following 
the method based on the Brazilian Pharmacopeia 
(Farmacopeia Brasileira, 2001).
Factorial design for extraction by maceration
 This study was carried out following a 32 
factorial model, taking into account the extraction time 
(5, 10 and 15 days) and the drug/solvent ratio (2.5, 
7.5 and 12.5%, w/v) as independent variables, and the 
total flavonoid content and dry residue as dependent 
variables. 
Chromatographic profile of selected extractive 
solution
 A new batch of extractive solution was 
produced, according to selected extraction conditions, 
in order to characterize its chromatographic profile 
by HPLC, using a Shimadzu LC-10AD HPLC system 
(Shimadzu, Tokyo, Japan) equipped with a binary pump 
and a SPD-M10A photo diode array detector, a CTO-
10A column oven, and an automatic injection system. 
The mobile phase consisted of water pH 3.2 (acidified 
with formic acid) as solvent A and acetonitrile: methanol 
(50:50, v/v) as solvent B, gradient system of 75:25 for 
30 min, to 60:40 on 20 min, 35 °C and flow rate of 0.8 
mL, through a C18 5 μm 100Å (250 x 4.6 mm) column 
(Phenomenex®, Torrance, USA), with detection at 254 
nm and injection of 20 μL. 
 All the solvents were HPLC grade and were 
previously degassed. The water was purified using an 
Easy Pure device (Waltham, Massachusetts, USA). 
For the LC injections, hydroethanolic extract was 
diluted in methanol and purified water (50:50) (5 mg/
mL, according to its dry residue weight). Isoquercitrin 
(Chromadex®, Irvine, CA), diluted in methanol and 
purified water (50:50), at six concentrations from 10 
to 80 μg/mL, was used as a reference substance to 
elaborate an analytical curve. All the samples were 
filtered through a 0.45 μm regenerated cellulose 
membrane (Millipore Maidstone, Kent, UK) before 
injection. Each analysis was repeated three times and 
the calibration curves were fitted by linear regression.
Animals
 Male wistar mice, 25-30 g, were used. The 
animals were kept in a controlled temperature room 
(23±2 °C), with 12 h light-dark cycles, and were 
allowed free access to food and water. The experiments 
were performed with the approval of the Committee for 
the Use of Animals in Experiments of the University of 
Itajaí Valley (Brazil) (CEUA 407/06), and were carried 
out in accordance with current guidelines for the 
care of laboratory animals, and the ethical guidelines 
for investigations of experimental pain in conscious 
animals, as specified by Zimmermann (1983). The 
number of animals (8-10 per group) and intensity of 
the noxious stimuli used were the minimum necessary 
to demonstrate the consistent effects of the drug 
treatments.
Antinociceptive activity
 The writhing test-abdominal constrictions 
resulting from intraperitoneal injection of acetic acid 
(0.6%), consisting of a contraction of the abdominal 
muscle together with a stretching of hind limbs-was 
carried out according to the procedures previously 
described (Collier et al., 1968; Santos et al., 2005). The 
animals were pretreated with the hydroethanolic extract 
through intraperitoneal (5-20 mg/kg) administration, 
30 min prior to acetic acid injection. The control 
animals received a similar volume of 0.9% NaCl (10 
mL/kg). Pairs of mice were then placed in separate 
boxes, and the number of abdominal constrictions 
was cumulatively counted over a period of 20 min. 
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Antinociceptive activity was expressed as the reduction 
in the number of abdominal constrictions between the 
control animals (saline pre-treated) and the mice pre-
treated with extract. The nociceptive response caused 
by acetic acid injection was analyzed 30 min after 
the administration of hydroethanolic extract or saline 
injection. All experiments were carried out at 20-22 
°C.
Anti-inflammatory activity
 The carrageenan (Cg) induced pleurisy 
model was used. Pleurisy experiments were carried 
out as previously described (Saleh et al., 1996) and 
carrageenan was used as the phlogistic agent, by a 
single intrapleural injection of 0.1 mL of Cg (1%). 
The animals were intraperitoneally treated with 
different doses of Ipomoea pes-caprae (L.) R. Br., 
Convolvulaceae, extract (5-20 mg/kg) or vehicle, 
used to dilute the extracts, or indomethacin (10 mg/
kg) as a reference drug, 30 min before the pleurisy 
induction. The inflammatory parameters (leukocytes 
and exudation) were analyzed 4 h after Cg injection.
 After 4 h, the animals were killed with an 
overdose of pentobarbital, the thorax was opened, 
and the pleural cavity was washed with 1.0 mL of 
sterile PBS (pH 7.6, NaCl 137 mM:KCl 2.7 mmol and 
phosphate buffer salts 10 mM) containing heparin (20 
IU/mL). Samples of the pleural lavage were collected 
to determine the exudation and total and differential 
leukocyte counts (Saleh et al., 1996; Dalmarco, 2002). 
Total leukocyte counts were performed in a Neubauer 
chamber after diluting the pleural fluid with Turk 
solution (1:20). The cytospin preparations of pleural 
wash were stained with May-Grunwald Giemsa for the 
differential count, which was performed under an oil 
immersion objective.
 In another set of experiments, the animals 
were treated 30 min before Cg, with a solution of Evans 
blue dye (2.5 mg/kg, 0.2 mL, i.v.) in order to evaluate 
the degree of exudation in the pleural space (Calixto & 
Campos, 1995). A sample (500 μL) of the fluid leakage 
collected from the pleural cavity was stored in a 
freezer (-20 °C) to further determine the concentration 
of Evans blue dye. To this end, on the day of the 
experiments, a batch of samples was thawed at room 
temperature and the amount of dye was estimated by 
optical density using a spectrophotometer (Pharmacia 
Biotech-Ultrospec 2000) at 600 nm, by interpolation 
from a standard curve of Evans blue dye in the range of 
0.01 to 50 μg/mL (Cordeiro et al., 1999).
Statistical analysis
 The factorial design 32 data were analyzed 
through response surface plots from adjusted equations 
by multiple regressions (Cochran & Cox, 1978; 
Montgomery, 1991), with the aid of Statgraphics Plus® 
(software version 5.1).
 The pharmacological results are presented as 
mean±standard error deviation (SEM). The statistical 
significance between groups was analyzed by means of 
t test or analysis of variance, followed by the Dunnet’s 
with the aid of GraphPad Instat® software. p values<0.05 
were considered as indicative of significance.
Results and discussion
 The batch of herb raw material used for this 
study was consisted by 52.24% of stems, 32.24% of 
leaves and 15.46% of buds, seeds and flowers, with 
a moisture content of 8.99±0.06, 11.76±0.81 and 
8.20±0.46, respectively, and was in accordance with 
acceptable values for preservation of the raw plant 
material in storage (Zhi-Chen, 1980). The mean particle 
size was 0.642 mm for the leaves, 0.657 mm for the 
stems and 0.698 mm for the buds, seeds and flowers 
together. 
 There were no statically differences among all 
the results of ethanol extractable matter, making this 
assay poorly discriminative (Table 1). However, the 
extraction of flavonoids was higher at 70 or 80 °GL 
ethanol. As no statistically differences were observed 
between the results, the 70 °GL was chosen due to its 
superior microbiological preservation properties.
Table 1. Ethanol extractable matter (EM) and total flavonoid 
content (TFC) of extractive solutions (1%, w/w and 5%, w/w, 
for EM and TFC assay, respectively). The results are expressed 
as mean±standard deviation (variation coefficient). 
Solvent EM (%, w/w) TFC (g%)
40° GL 32.15±0.85 (2.65) 0.0739±0.0037 (4.98)
50° GL 35.13±2.56 (7.27) 0.0574±0.0020 (3.45)
60° GL 32.34±4.43 (13.68) 0.0530±0.0115 (21.77)
70° GL 36.88±3.68 (9.97) 0.0921±0.0100 (10.90)
80° GL 30.85±4.68 (15.16) 0.0877±0.0011 (1.29)
 The factorial design was then applied, in 
order to find out the best drug/solvent proportion and 
extraction time for the maceration process. Dry residue 
was investigated for its importance in yield calculations 
in further studies with technological purposes, such as 
the drying process. Flavonoids were chosen as chemical 
markers in this study because of their well-known 
antinociceptive and anti-inflammatory properties 
(Muschietti & Martino, 2007). The main flavonoid 
from this plant, isoquercitrin, proved to be one of the 
active principles of this plant (Krogh et al., 1999). 
 The studied responses (Dry residue 
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or TFC) (Table 2) were adjusted by a second 
order mathematic model, according to the 
following equation: Y=β0+β1*Conc+β2*T+β12 
Conc*T+β11*Conc2+β22*T2 , where y=studied 
response, β0... β22 =coefficients, Conc=concentration 
(%, w/v) of I. pes-caprae aerial parts, T=extraction 
time. The experimental data were adjusted by the 
quadratic model, resulting in the following equations: 
y=-0 .372+0 .637*Conc+0 .078*T-0 .014*Conc 2-
0.014*Conc*T-0.0015*T2 for dry residue (r2=0.9908) 
and y=-0.058+0.010*Conc+0.017*T-4*10-5*Conc2-
4.04*10-4*Conc*T-8.64*10-4*T2 for TFC (r2=0.9143), 
where Conc=herb drug concentration (%, w/v) and 
T=extraction time (days).
Table 2. Total flavonoid content (TFC, g%) and dry residue 
for extractive solutions (ES) obtained according 32 factorial 
design. 
ES (Conc+T) TFC (g%) Dry Residue (%)
1 (2.5+5) 0.0273±0.0025 1.399±0.130
2 (7.5+5) 0.0781±0.0005 3.311±0.062
3 (12.5+5) 0.0926±0.0006 4.812±0.180
4 (2.5+10) 0.0343±0.0006 1.370±0.045
5 (7.5+10) 0.0687±0.0040 3.047±0.045
6 (12.5+10) 0.1125±0.0007 4.321±0.022
7 (2.5+15) 0.0266±0.0004 1.358±0.058
8 (7.5+15) 0.0277±0.0004 3.023±0.085
9 (12.5+15) 0.0519±0.0003 3.341±0.209
Conc: herb drug concentration (%; w/v); T: extraction time (day). 
The results are expressed as mean±standard deviation.
 According to the statistical analysis for the 
dry residue, concentration (p=0.0004) had the highest 
significance compared to the other variables, like time 
(p=0.0347) and the interaction of these factors (0.0372) 
(Figure 1A). For the TFC, only the linear coefficient of 
concentration demonstrated significance (p=0.0204) as 
reflected by the surface plot (Figure 1B). 
 Both response surface plots indicated the best 
conditions for extraction in order to obtain higher 
levels of dry residue (Figure 1A) and flavonoid content 
(Figure 1B): 12.5% (w/v), due to their drug:solvent 
ratio and extraction time of about seven days.
 Through the factorial experiment, it was possible 
to choice the most favorable extraction conditions, with a 
view to achieving greater efficiency in terms of flavonoids 
and dry residue. Both the total flavonoid content and the 
dry residue were strongly influenced by extraction time 
and drug:solvent ratio, particularly the latter. According to 
the response surface plot, the dried, powdered plant matter 
of 12.5% (w/v), placed in contact with 70 °GL ethanol 
over a period of five to seven days, obtained higher yields 
in terms of dry residue and total flavonoid content.
Figure 1. Response Surface plot for evaluating the influence of 
herb drug concentration and extraction time on the dry residue 
(A); and on the total flavonoid content (TFC) (B).
Chromatographic profile of optimized extractive 
solution
 Another batch was also produced, for the sole 
purpose of identifying a possible flavonoid marker. The 
new batch was produced using a drug/solvent ratio of 
12.5% (g/mL) and extraction time of seven days, taking 
into account the conditions set by the response surface plot 
(Figure 1B). 
 Figure 2 shows the chromatographic profile of 
ES with six peaks. Only two of them (1 and 2) have 
a characteristic UV absorbance profile of flavonoids. 
The second peak was identified as isoquercitrin, since 
it was eluted at the same retention time (about 17.66 
min) and had the same UV absorbance profile (data not 
show). The isoquercitrin concentration was calculated 
from the linear regression equation y=48487x-3145.3 
(r2=0.9999). In this batch, there was 71.3±7.7 μg/mL of 
isoquercitrin, corresponding to 3.1 mg/g, considering 
its extractive solution dry residue weight of 2.3 g% 
(w/w). 
Pharmacological evaluation
 The extractive solution that showed the highest 
TFC (ES6, Table 2) was chosen for the evaluation of 
antinociceptive activity by the writhing test, and anti-
inflammatory activity by the pleurisy model. 
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Antinociceptive activity by the Writhing test
 The results (Figure 3) demonstrate that I. pes-
caprae hydroethanolic extract, given by i.p. 30 min 
prior to testing, produced dose-related inhibition of 
acetic acid-induced abdominal constrictions in mice, 
with MI (Maximum inhibition) and calculated DI50 of 
55.88±2.4% and 17.34 (12.23-24.30) mg/kg, respectively. 
Indomethacin, used in this experiment as positive control, 
also reduced the number of writhings induced by acetic 
acid, with inhibition of 64.86% at 10 mg/kg.
Figure 2. Chromatographic profile of Ipomoea pes-caprae 
hydroethanolic extract solution (new batch obtained as 
established by the response surface plot) at 5 mg.mL-1 of 
dried residue, monitored at 254 nm (2=isoquercitrin).
Figure 3. Effects of hydroethanolic extract (ES6, Table 2) of 
I. pes-caprae on the number of acetic acid induced writhings 
in mice. Each column represents the average of 8 animals per 
group and the vertical bars represent the EPMs. The asterisks 
denote statistical significance (**p<0.01) when compared 
with the control group (vehicle). ANOVA, complemented by 
the Dunnnet’s test.
 Our results show that the optimized 
hydroethanolic extractive solution was able to inhibit 
more than 50% of abdominal writhings at 20 mg/
kg, being more effective than the methanol extract 
evaluated earlier by Krogh et al. (1999) and Souza et al. 
(2000), which showed a DI50 of 33.8 mg/kg under the 
Figure 4. Effects of hydroethanolic extract (ES6, Table 2) of I. pes-caprae (5-20 mg.kg-1, i.p.) upon inflammatory parameters 
in the mice model of pleurisy. (A) exudate, (B) total leukocytes, (C) neutrophils and (D) mononuclear cells. Each column 
represents the average of 6 to 8 animals and the vertical bars represent the EPM. Asterisks denote statistical significance 
(**p<0.01) when compared with carrageenan and ≠ p<0.05 when compared with the control group (saline). ANOVA, 
complemented by the Dunnet’s test.
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same experimental conditions. Moreover, the solvent 
used in our work presents advantages over other toxic 
or more polluting organic solvents, being more useful 
and suitable for the phytopharmaceutical industry.
 With respect to the phytochemical constituents 
isolated from I. pes-caprae related to these activities, 
Krogh et al. (1999) showed that some triterpenes 
and isoquercitrin significantly inhibited acetic 
acid-induced abdominal constrictions in mice. The 
selected hydroethanolic extractive solution also 
showed significant inhibition, being more active than 
isoquercitrin itself and some triterpenes, suggesting the 
occurrence of synergism, and the fact that flavonoids 
such as isoquercitrin detected in the extract (Figure 
2) are not the only substances responsible for the 
activity. 
 Carrageenan-induced pleurisy
 In the present study, it was found that the extract 
of I. pes-caprae (5, 10, 15 and 20 mg/kg, i.p.) was able 
to induce significant and dose-dependant inhibition of 
the first phase of inflammation (4 h) of the pleural cavity 
induced by injection of carrageenan (1%) in mice. It was 
observed that the extract of I. pes-caprae caused, to a lesser 
extent, a reduction in carrageenan-induced exudation (% 
inhibition: 50±0.82) (p<0.01) (Figure 4A). Moreover, 
the extract produced inhibition of cell migration (number 
of total leukocytes) to the pleural cavity (% inhibition: 
60.88±0.14) (p<0.01) (Figure 4B), mainly represented 
by neutrophils (% inhibition: 88.90±0.12) (p<0.01) 
(Figure 4C). However, the extract produced an increase 
in migration of mononuclear cells (Figure 4D) to the 
inflammatory site.
 In carrageenan-induced pleurisy in mice, 
a model of inflammation, carrageenan promotes an 
increase in the volume of exudate in the pleural cavity, 
leukocyte migration of the polymorphonuclear type, 
and participation of some inflammatory mediators such 
as histamine, serotonin bradykinin, nitric oxide (NO), 
TNFα and IL-1β, substance P (SP) and others (Saleh 
et al. 1996, 1999; Endo, 2001; Banerjee et al. 2002; 
Brennan & Mclnnes, 2008). 
 Regarding the inflammatory process, there are 
few reports on I. pes-caprae in the literature. It is known 
that the plant antagonizes the effects of histamine and also 
inhibits the release of prostaglandins (Pongrayoon et al., 
1991b). Rogers et al. (2000) showed that the methanol 
extract of this plant potently inhibited ADP induced 
human platelet [14C]5-HT release in vitro, with levels of 
inhibition ranging from 62 to 95%. 
 The increase in migration of mononuclear 
cells to the inflammatory site is probably related to 
the immunostimulatory activity, and appears to be 
independent of the type of plant extract used. Philippi 
et al. (2010) demonstrated that I. pes-caprae methanol 
extract has already been shown to induce human T 
lymphocyte proliferation. 
 The pharmacological results performed with 
I. pes-caprae hydroethanolic extract also suggest 
analgesic and anti-inflammatory effects similar to those 
previously demonstrated by methanol extract, ethyl 
acetate and aqueous fractions of I. pes-caprae (Krogh 
et al., 1999). Indeed, this work was able to validate the 
technological conditions of the maceration process to 
produce a bioactive plant extract for the development 
of phytopharmaceuticals. Further studies are necessary 
to elucidate the mechanism of action of this extract.
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